Literature DB >> 14716070

Severe bronchiolitis in children.

Sanjay Jhawar1.   

Abstract

Bronchiolitis is a common, acute, contagious lower respiratory tract illness of infants and young children. The majority of cases are secondary to respiratory syncytial virus. There are a number of risk factors for severe disease, including children less than six weeks of age and patients with atopy and/or asthma. The management requires vigilant monitoring and high-quality supportive care, including impressive use of fluids and nutritional support. Further research on anti-virals is essential to prevent respiratory syncytial virus induced bronchiolitis. Fortunately, the prognosis for the majority of normal infants who develop bronchiolitis is good.

Entities:  

Mesh:

Year:  2003        PMID: 14716070      PMCID: PMC7102321          DOI: 10.1385/CRIAI:25:3:249

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  27 in total

1.  Efficacy of bronchodilator therapy in bronchiolitis. A meta-analysis.

Authors:  J D Kellner; A Ohlsson; A M Gadomski; E E Wang
Journal:  Arch Pediatr Adolesc Med       Date:  1996-11

2.  A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis.

Authors:  Hans Bisgaard
Journal:  Am J Respir Crit Care Med       Date:  2002-10-03       Impact factor: 21.405

Review 3.  Acute viral bronchiolitis in infancy: epidemiology and management.

Authors:  T Nicolai; A Pohl
Journal:  Lung       Date:  1990       Impact factor: 2.584

4.  Use of montelukast in the treatment of early childhood wheezing from clinical experience with three cases.

Authors:  D K Ng; A K Law; K W Chau; H K Chan
Journal:  Respirology       Date:  2000-12       Impact factor: 6.424

5.  Efficacy of oral dexamethasone in outpatients with acute bronchiolitis.

Authors:  Suzanne Schuh; Allan L Coates; Rosemary Binnie; Tracey Allin; Cristina Goia; Mary Corey; Paul T Dick
Journal:  J Pediatr       Date:  2002-01       Impact factor: 4.406

Review 6.  Does nebulised adrenaline (epinephrine) reduce admission rate in bronchiolitis?

Authors:  Maud Meates
Journal:  Arch Dis Child       Date:  2002-12       Impact factor: 3.791

Review 7.  Respiratory syncytial virus infection.

Authors:  E A Simoes
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

8.  Respiratory failure and mechanical ventilation in severe bronchiolitis.

Authors:  M H Lebel; M Gauthier; J Lacroix; E Rousseau; M Buithieu
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

9.  Steroids fail to down-regulate respiratory syncytial virus-induced IL-8 secretion in infants.

Authors:  Lynette H Thomas; Mike Sharland; Jon S Friedland
Journal:  Pediatr Res       Date:  2002-09       Impact factor: 3.756

Review 10.  Clinical perspectives on the association between respiratory syncytial virus and reactive airway disease.

Authors:  Nele Sigurs
Journal:  Respir Res       Date:  2002-06-24
View more
  3 in total

Review 1.  Respiratory syncytial virus bronchiolitis.

Authors:  Alexander K C Leung; James D Kellner; H Dele Davies
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

Review 2.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

3.  The effect of outdoor air pollution on the risk of hospitalisation for bronchiolitis in infants: a systematic review.

Authors:  Charlotte King; Daniel Hawcutt; Ian Sinha; Jamie Kirkham
Journal:  PeerJ       Date:  2018-08-28       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.